Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Exome Asset Management LLC (CIK 2011932) reported $162.1M across 52 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: GH ($10.1M, 6.25%), PRAX ($9.1M, 5.62%), TGTX ($9.1M, 5.59%), COGT ($8.1M, 5.03%), IONS ($7.0M, 4.31%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | GH | GUARDANT HEALTH INC | $10.1M | 6.25% | 67,500 | Trimmed |
| 2 | PRAX | PRAXIS PRECISION MEDICINES I | $9.1M | 5.62% | 27,205 | Trimmed |
| 3 | TGTX | TG THERAPEUTICS INC | $9.1M | 5.59% | 164,915 | New |
| 4 | COGT | COGENT BIOSCIENCES INC | $8.1M | 5.03% | 210,523 | Trimmed |
| 5 | IONS | IONIS PHARMACEUTICALS INC | $7.0M | 4.31% | 88,177 | Trimmed |
| 6 | LLY | ELI LILLY & CO | $6.6M | 4.06% | 5,492 | Trimmed |
| 7 | ABVX | ABIVAX SA | $6.2M | 3.85% | 46,878 | New |
| 8 | ALMS | ALUMIS INC | $5.8M | 3.55% | 204,418 | Trimmed |
| 9 | CYTK | CYTOKINETICS INC | $5.1M | 3.16% | 60,056 | Trimmed |
| 10 | ELVN | ENLIVEN THERAPEUTICS INC | $5.1M | 3.14% | 100,203 | Trimmed |
| 11 | VERA | VERA THERAPEUTICS INC | $4.2M | 2.57% | 97,276 | Trimmed |
| 12 | UNH | UNITEDHEALTH GROUP INC | $4.0M | 2.46% | 9,612 | Trimmed |
| 13 | TXG | 10X GENOMICS INC | $3.9M | 2.43% | 102,629 | Trimmed |
| 14 | NTRA | NATERA INC | $3.7M | 2.31% | 13,800 | Trimmed |
| 15 | QURE | UNIQURE NV | $3.7M | 2.30% | 81,056 | New |
| 16 | RYTM | RHYTHM PHARMACEUTICALS INC | $3.6M | 2.21% | 32,209 | Trimmed |
| 17 | MAZE | MAZE THERAPEUTICS INC | $3.4M | 2.11% | 114,692 | Added |
| 18 | GLUE | MONTE ROSA THERAPEUTICS INC | $3.3M | 2.05% | 137,115 | Trimmed |
| 19 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $3.2M | 2.00% | 166,493 | Trimmed |
| 20 | ALKS | ALKERMES PLC | $3.2M | 1.98% | 61,336 | Trimmed |
| 21 | LQDA | LIQUIDIA CORPORATION | $3.1M | 1.93% | 39,224 | Trimmed |
| 22 | UTHR | UNITED THERAPEUTICS CORP DEL | $2.9M | 1.81% | 5,410 | Trimmed |
| 23 | GKOS | GLAUKOS CORP | $2.8M | 1.71% | 19,862 | Trimmed |
| 24 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $2.6M | 1.62% | 32,214 | Trimmed |
| 25 | AGIO | AGIOS PHARMACEUTICALS INC | $2.6M | 1.61% | 70,500 | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30